Yi‐Kun Kang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College

发表论文 27 篇 · 总被引 185 次 · h-index 8

代表论文

• The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors (2019 · Translational Cancer Research · 被引 44)
• Liquid-based biomarkers in breast cancer: looking beyond the blood (2023 · Journal of Translational Medicine · 被引 29)
• The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer (2021 · Frontiers in Oncology · 被引 18)
• Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis (2023 · Frontiers in Oncology · 被引 13)
• Efficacy and safety of cyclophosphamide in anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer: a meta-analysis (2021 · Gland Surgery · 被引 12)
• Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2 -Negative and Lymph Node–Positive Breast Cancer (2023 · JAMA Network Open · 被引 10)